Global Gene Delivery System Supply, Demand and Key Producers, 2024-2030

Global Gene Delivery System Supply, Demand and Key Producers, 2024-2030

Page: 115

Published Date: 27 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Gene Delivery System market size is expected to reach $ 37570 million by 2030, rising at a market growth of 26.4% CAGR during the forecast period (2024-2030).

Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.

Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

This report studies the global Gene Delivery System demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Delivery System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Delivery System that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gene Delivery System total market, 2019-2030, (USD Million)
Global Gene Delivery System total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Gene Delivery System total market, key domestic companies and share, (USD Million)
Global Gene Delivery System revenue by player and market share 2019-2024, (USD Million)
Global Gene Delivery System total market by Type, CAGR, 2019-2030, (USD Million)
Global Gene Delivery System total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Gene Delivery System market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Delivery System market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gene Delivery System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gene Delivery System Market, Segmentation by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Global Gene Delivery System Market, Segmentation by Application
Neurological Diseases
Cancer
Others

Companies Profiled:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Key Questions Answered
1. How big is the global Gene Delivery System market?
2. What is the demand of the global Gene Delivery System market?
3. What is the year over year growth of the global Gene Delivery System market?
4. What is the total value of the global Gene Delivery System market?
5. Who are the major players in the global Gene Delivery System market?
btl

Table of Contents

1 Supply Summary
1.1 Gene Delivery System Introduction
1.2 World Gene Delivery System Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Gene Delivery System Total Market by Region (by Headquarter Location)
1.3.1 World Gene Delivery System Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Gene Delivery System Market Size (2019-2030)
1.3.3 China Gene Delivery System Market Size (2019-2030)
1.3.4 Europe Gene Delivery System Market Size (2019-2030)
1.3.5 Japan Gene Delivery System Market Size (2019-2030)
1.3.6 South Korea Gene Delivery System Market Size (2019-2030)
1.3.7 ASEAN Gene Delivery System Market Size (2019-2030)
1.3.8 India Gene Delivery System Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Delivery System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Delivery System Major Market Trends

2 Demand Summary
2.1 World Gene Delivery System Consumption Value (2019-2030)
2.2 World Gene Delivery System Consumption Value by Region
2.2.1 World Gene Delivery System Consumption Value by Region (2019-2024)
2.2.2 World Gene Delivery System Consumption Value Forecast by Region (2025-2030)
2.3 United States Gene Delivery System Consumption Value (2019-2030)
2.4 China Gene Delivery System Consumption Value (2019-2030)
2.5 Europe Gene Delivery System Consumption Value (2019-2030)
2.6 Japan Gene Delivery System Consumption Value (2019-2030)
2.7 South Korea Gene Delivery System Consumption Value (2019-2030)
2.8 ASEAN Gene Delivery System Consumption Value (2019-2030)
2.9 India Gene Delivery System Consumption Value (2019-2030)

3 World Gene Delivery System Companies Competitive Analysis
3.1 World Gene Delivery System Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Delivery System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Delivery System in 2023
3.2.3 Global Concentration Ratios (CR8) for Gene Delivery System in 2023
3.3 Gene Delivery System Company Evaluation Quadrant
3.4 Gene Delivery System Market: Overall Company Footprint Analysis
3.4.1 Gene Delivery System Market: Region Footprint
3.4.2 Gene Delivery System Market: Company Product Type Footprint
3.4.3 Gene Delivery System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Gene Delivery System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Delivery System Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Gene Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Gene Delivery System Consumption Value Comparison
4.2.1 United States VS China: Gene Delivery System Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Gene Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Gene Delivery System Companies and Market Share, 2019-2024
4.3.1 United States Based Gene Delivery System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Delivery System Revenue, (2019-2024)
4.4 China Based Companies Gene Delivery System Revenue and Market Share, 2019-2024
4.4.1 China Based Gene Delivery System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Delivery System Revenue, (2019-2024)
4.5 Rest of World Based Gene Delivery System Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Gene Delivery System Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Delivery System Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Gene Delivery System Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Viral Gene Delivery System
5.2.2 Non-viral Gene Delivery System
5.3 Market Segment by Type
5.3.1 World Gene Delivery System Market Size by Type (2019-2024)
5.3.2 World Gene Delivery System Market Size by Type (2025-2030)
5.3.3 World Gene Delivery System Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Gene Delivery System Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Gene Delivery System Market Size by Application (2019-2024)
6.3.2 World Gene Delivery System Market Size by Application (2025-2030)
6.3.3 World Gene Delivery System Market Size by Application (2019-2030)

7 Company Profiles
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene Delivery System Product and Services
7.1.4 Biogen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene Delivery System Product and Services
7.2.4 Novartis Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene Delivery System Product and Services
7.3.4 Gilead Sciences Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene Delivery System Product and Services
7.4.4 Sarepta Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene Delivery System Product and Services
7.5.4 Alnylam Pharmaceuticals Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene Delivery System Product and Services
7.6.4 Amgen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Details
7.7.2 Spark Therapeutics Major Business
7.7.3 Spark Therapeutics Gene Delivery System Product and Services
7.7.4 Spark Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Spark Therapeutics Recent Developments/Updates
7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene Delivery System Product and Services
7.8.4 Akcea Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 bluebird bio
7.9.1 bluebird bio Details
7.9.2 bluebird bio Major Business
7.9.3 bluebird bio Gene Delivery System Product and Services
7.9.4 bluebird bio Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 bluebird bio Recent Developments/Updates
7.9.6 bluebird bio Competitive Strengths & Weaknesses
7.10 Sunway Biotech
7.10.1 Sunway Biotech Details
7.10.2 Sunway Biotech Major Business
7.10.3 Sunway Biotech Gene Delivery System Product and Services
7.10.4 Sunway Biotech Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Sunway Biotech Recent Developments/Updates
7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
7.11 SIBIONO
7.11.1 SIBIONO Details
7.11.2 SIBIONO Major Business
7.11.3 SIBIONO Gene Delivery System Product and Services
7.11.4 SIBIONO Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 SIBIONO Recent Developments/Updates
7.11.6 SIBIONO Competitive Strengths & Weaknesses
7.12 AnGes
7.12.1 AnGes Details
7.12.2 AnGes Major Business
7.12.3 AnGes Gene Delivery System Product and Services
7.12.4 AnGes Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 AnGes Recent Developments/Updates
7.12.6 AnGes Competitive Strengths & Weaknesses
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Details
7.13.2 Orchard Therapeutics Major Business
7.13.3 Orchard Therapeutics Gene Delivery System Product and Services
7.13.4 Orchard Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Orchard Therapeutics Recent Developments/Updates
7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Details
7.14.2 Human Stem Cells Institute Major Business
7.14.3 Human Stem Cells Institute Gene Delivery System Product and Services
7.14.4 Human Stem Cells Institute Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Human Stem Cells Institute Recent Developments/Updates
7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Gene Delivery System Industry Chain
8.2 Gene Delivery System Upstream Analysis
8.3 Gene Delivery System Midstream Analysis
8.4 Gene Delivery System Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Gene Delivery System Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Gene Delivery System Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Gene Delivery System Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Gene Delivery System Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Gene Delivery System Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Delivery System Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Gene Delivery System Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Gene Delivery System Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Gene Delivery System Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Gene Delivery System Players in 2023
Table 12. World Gene Delivery System Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Gene Delivery System Company Evaluation Quadrant
Table 14. Head Office of Key Gene Delivery System Player
Table 15. Gene Delivery System Market: Company Product Type Footprint
Table 16. Gene Delivery System Market: Company Product Application Footprint
Table 17. Gene Delivery System Mergers & Acquisitions Activity
Table 18. United States VS China Gene Delivery System Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Gene Delivery System Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Gene Delivery System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 23. China Based Gene Delivery System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 26. Rest of World Based Gene Delivery System Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 29. World Gene Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Gene Delivery System Market Size by Type (2019-2024) & (USD Million)
Table 31. World Gene Delivery System Market Size by Type (2025-2030) & (USD Million)
Table 32. World Gene Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Gene Delivery System Market Size by Application (2019-2024) & (USD Million)
Table 34. World Gene Delivery System Market Size by Application (2025-2030) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene Delivery System Product and Services
Table 38. Biogen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene Delivery System Product and Services
Table 44. Novartis Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Area Served and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene Delivery System Product and Services
Table 50. Gilead Sciences Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene Delivery System Product and Services
Table 56. Sarepta Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene Delivery System Product and Services
Table 62. Alnylam Pharmaceuticals Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Area Served and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene Delivery System Product and Services
Table 68. Amgen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
Table 72. Spark Therapeutics Major Business
Table 73. Spark Therapeutics Gene Delivery System Product and Services
Table 74. Spark Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Spark Therapeutics Recent Developments/Updates
Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene Delivery System Product and Services
Table 80. Akcea Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. bluebird bio Basic Information, Area Served and Competitors
Table 84. bluebird bio Major Business
Table 85. bluebird bio Gene Delivery System Product and Services
Table 86. bluebird bio Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. bluebird bio Recent Developments/Updates
Table 88. bluebird bio Competitive Strengths & Weaknesses
Table 89. Sunway Biotech Basic Information, Area Served and Competitors
Table 90. Sunway Biotech Major Business
Table 91. Sunway Biotech Gene Delivery System Product and Services
Table 92. Sunway Biotech Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Sunway Biotech Recent Developments/Updates
Table 94. Sunway Biotech Competitive Strengths & Weaknesses
Table 95. SIBIONO Basic Information, Area Served and Competitors
Table 96. SIBIONO Major Business
Table 97. SIBIONO Gene Delivery System Product and Services
Table 98. SIBIONO Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. SIBIONO Recent Developments/Updates
Table 100. SIBIONO Competitive Strengths & Weaknesses
Table 101. AnGes Basic Information, Area Served and Competitors
Table 102. AnGes Major Business
Table 103. AnGes Gene Delivery System Product and Services
Table 104. AnGes Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. AnGes Recent Developments/Updates
Table 106. AnGes Competitive Strengths & Weaknesses
Table 107. Orchard Therapeutics Basic Information, Area Served and Competitors
Table 108. Orchard Therapeutics Major Business
Table 109. Orchard Therapeutics Gene Delivery System Product and Services
Table 110. Orchard Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Orchard Therapeutics Recent Developments/Updates
Table 112. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 113. Human Stem Cells Institute Major Business
Table 114. Human Stem Cells Institute Gene Delivery System Product and Services
Table 115. Human Stem Cells Institute Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of Gene Delivery System Upstream (Raw Materials)
Table 117. Gene Delivery System Typical Customers
List of Figure
Figure 1. Gene Delivery System Picture
Figure 2. World Gene Delivery System Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Gene Delivery System Total Market Size (2019-2030) & (USD Million)
Figure 4. World Gene Delivery System Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Delivery System Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 13. Gene Delivery System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 16. World Gene Delivery System Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 18. China Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 23. India Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Gene Delivery System by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Delivery System Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Delivery System Markets in 2023
Figure 27. United States VS China: Gene Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Gene Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Gene Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Gene Delivery System Market Size Market Share by Type in 2023
Figure 31. Viral Gene Delivery System
Figure 32. Non-viral Gene Delivery System
Figure 33. World Gene Delivery System Market Size Market Share by Type (2019-2030)
Figure 34. World Gene Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Gene Delivery System Market Size Market Share by Application in 2023
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Others
Figure 39. Gene Delivery System Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Gene Delivery System Supply, Demand and Key Producers, 2024-2030

Global Gene Delivery System Supply, Demand and Key Producers, 2024-2030

Page: 115

Published Date: 27 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Gene Delivery System market size is expected to reach $ 37570 million by 2030, rising at a market growth of 26.4% CAGR during the forecast period (2024-2030).

Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.

Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

This report studies the global Gene Delivery System demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Delivery System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Delivery System that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gene Delivery System total market, 2019-2030, (USD Million)
Global Gene Delivery System total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Gene Delivery System total market, key domestic companies and share, (USD Million)
Global Gene Delivery System revenue by player and market share 2019-2024, (USD Million)
Global Gene Delivery System total market by Type, CAGR, 2019-2030, (USD Million)
Global Gene Delivery System total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Gene Delivery System market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Delivery System market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gene Delivery System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gene Delivery System Market, Segmentation by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Global Gene Delivery System Market, Segmentation by Application
Neurological Diseases
Cancer
Others

Companies Profiled:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Key Questions Answered
1. How big is the global Gene Delivery System market?
2. What is the demand of the global Gene Delivery System market?
3. What is the year over year growth of the global Gene Delivery System market?
4. What is the total value of the global Gene Delivery System market?
5. Who are the major players in the global Gene Delivery System market?
btl

Table of Contents

1 Supply Summary
1.1 Gene Delivery System Introduction
1.2 World Gene Delivery System Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Gene Delivery System Total Market by Region (by Headquarter Location)
1.3.1 World Gene Delivery System Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Gene Delivery System Market Size (2019-2030)
1.3.3 China Gene Delivery System Market Size (2019-2030)
1.3.4 Europe Gene Delivery System Market Size (2019-2030)
1.3.5 Japan Gene Delivery System Market Size (2019-2030)
1.3.6 South Korea Gene Delivery System Market Size (2019-2030)
1.3.7 ASEAN Gene Delivery System Market Size (2019-2030)
1.3.8 India Gene Delivery System Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Delivery System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Delivery System Major Market Trends

2 Demand Summary
2.1 World Gene Delivery System Consumption Value (2019-2030)
2.2 World Gene Delivery System Consumption Value by Region
2.2.1 World Gene Delivery System Consumption Value by Region (2019-2024)
2.2.2 World Gene Delivery System Consumption Value Forecast by Region (2025-2030)
2.3 United States Gene Delivery System Consumption Value (2019-2030)
2.4 China Gene Delivery System Consumption Value (2019-2030)
2.5 Europe Gene Delivery System Consumption Value (2019-2030)
2.6 Japan Gene Delivery System Consumption Value (2019-2030)
2.7 South Korea Gene Delivery System Consumption Value (2019-2030)
2.8 ASEAN Gene Delivery System Consumption Value (2019-2030)
2.9 India Gene Delivery System Consumption Value (2019-2030)

3 World Gene Delivery System Companies Competitive Analysis
3.1 World Gene Delivery System Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Delivery System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Delivery System in 2023
3.2.3 Global Concentration Ratios (CR8) for Gene Delivery System in 2023
3.3 Gene Delivery System Company Evaluation Quadrant
3.4 Gene Delivery System Market: Overall Company Footprint Analysis
3.4.1 Gene Delivery System Market: Region Footprint
3.4.2 Gene Delivery System Market: Company Product Type Footprint
3.4.3 Gene Delivery System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Gene Delivery System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Delivery System Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Gene Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Gene Delivery System Consumption Value Comparison
4.2.1 United States VS China: Gene Delivery System Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Gene Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Gene Delivery System Companies and Market Share, 2019-2024
4.3.1 United States Based Gene Delivery System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Delivery System Revenue, (2019-2024)
4.4 China Based Companies Gene Delivery System Revenue and Market Share, 2019-2024
4.4.1 China Based Gene Delivery System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Delivery System Revenue, (2019-2024)
4.5 Rest of World Based Gene Delivery System Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Gene Delivery System Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Delivery System Revenue, (2019-2024)

5 Market Analysis by Type
5.1 World Gene Delivery System Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Viral Gene Delivery System
5.2.2 Non-viral Gene Delivery System
5.3 Market Segment by Type
5.3.1 World Gene Delivery System Market Size by Type (2019-2024)
5.3.2 World Gene Delivery System Market Size by Type (2025-2030)
5.3.3 World Gene Delivery System Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
6.1 World Gene Delivery System Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Gene Delivery System Market Size by Application (2019-2024)
6.3.2 World Gene Delivery System Market Size by Application (2025-2030)
6.3.3 World Gene Delivery System Market Size by Application (2019-2030)

7 Company Profiles
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene Delivery System Product and Services
7.1.4 Biogen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene Delivery System Product and Services
7.2.4 Novartis Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene Delivery System Product and Services
7.3.4 Gilead Sciences Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene Delivery System Product and Services
7.4.4 Sarepta Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene Delivery System Product and Services
7.5.4 Alnylam Pharmaceuticals Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene Delivery System Product and Services
7.6.4 Amgen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Details
7.7.2 Spark Therapeutics Major Business
7.7.3 Spark Therapeutics Gene Delivery System Product and Services
7.7.4 Spark Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Spark Therapeutics Recent Developments/Updates
7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene Delivery System Product and Services
7.8.4 Akcea Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 bluebird bio
7.9.1 bluebird bio Details
7.9.2 bluebird bio Major Business
7.9.3 bluebird bio Gene Delivery System Product and Services
7.9.4 bluebird bio Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 bluebird bio Recent Developments/Updates
7.9.6 bluebird bio Competitive Strengths & Weaknesses
7.10 Sunway Biotech
7.10.1 Sunway Biotech Details
7.10.2 Sunway Biotech Major Business
7.10.3 Sunway Biotech Gene Delivery System Product and Services
7.10.4 Sunway Biotech Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Sunway Biotech Recent Developments/Updates
7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
7.11 SIBIONO
7.11.1 SIBIONO Details
7.11.2 SIBIONO Major Business
7.11.3 SIBIONO Gene Delivery System Product and Services
7.11.4 SIBIONO Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 SIBIONO Recent Developments/Updates
7.11.6 SIBIONO Competitive Strengths & Weaknesses
7.12 AnGes
7.12.1 AnGes Details
7.12.2 AnGes Major Business
7.12.3 AnGes Gene Delivery System Product and Services
7.12.4 AnGes Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 AnGes Recent Developments/Updates
7.12.6 AnGes Competitive Strengths & Weaknesses
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Details
7.13.2 Orchard Therapeutics Major Business
7.13.3 Orchard Therapeutics Gene Delivery System Product and Services
7.13.4 Orchard Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Orchard Therapeutics Recent Developments/Updates
7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Details
7.14.2 Human Stem Cells Institute Major Business
7.14.3 Human Stem Cells Institute Gene Delivery System Product and Services
7.14.4 Human Stem Cells Institute Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Human Stem Cells Institute Recent Developments/Updates
7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Gene Delivery System Industry Chain
8.2 Gene Delivery System Upstream Analysis
8.3 Gene Delivery System Midstream Analysis
8.4 Gene Delivery System Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Gene Delivery System Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Gene Delivery System Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Gene Delivery System Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Gene Delivery System Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Gene Delivery System Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Delivery System Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Gene Delivery System Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Gene Delivery System Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Gene Delivery System Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Gene Delivery System Players in 2023
Table 12. World Gene Delivery System Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Gene Delivery System Company Evaluation Quadrant
Table 14. Head Office of Key Gene Delivery System Player
Table 15. Gene Delivery System Market: Company Product Type Footprint
Table 16. Gene Delivery System Market: Company Product Application Footprint
Table 17. Gene Delivery System Mergers & Acquisitions Activity
Table 18. United States VS China Gene Delivery System Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Gene Delivery System Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Gene Delivery System Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 23. China Based Gene Delivery System Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 26. Rest of World Based Gene Delivery System Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Delivery System Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Gene Delivery System Revenue Market Share (2019-2024)
Table 29. World Gene Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Gene Delivery System Market Size by Type (2019-2024) & (USD Million)
Table 31. World Gene Delivery System Market Size by Type (2025-2030) & (USD Million)
Table 32. World Gene Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Gene Delivery System Market Size by Application (2019-2024) & (USD Million)
Table 34. World Gene Delivery System Market Size by Application (2025-2030) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene Delivery System Product and Services
Table 38. Biogen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene Delivery System Product and Services
Table 44. Novartis Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Area Served and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene Delivery System Product and Services
Table 50. Gilead Sciences Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene Delivery System Product and Services
Table 56. Sarepta Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene Delivery System Product and Services
Table 62. Alnylam Pharmaceuticals Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Area Served and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene Delivery System Product and Services
Table 68. Amgen Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
Table 72. Spark Therapeutics Major Business
Table 73. Spark Therapeutics Gene Delivery System Product and Services
Table 74. Spark Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Spark Therapeutics Recent Developments/Updates
Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene Delivery System Product and Services
Table 80. Akcea Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. bluebird bio Basic Information, Area Served and Competitors
Table 84. bluebird bio Major Business
Table 85. bluebird bio Gene Delivery System Product and Services
Table 86. bluebird bio Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. bluebird bio Recent Developments/Updates
Table 88. bluebird bio Competitive Strengths & Weaknesses
Table 89. Sunway Biotech Basic Information, Area Served and Competitors
Table 90. Sunway Biotech Major Business
Table 91. Sunway Biotech Gene Delivery System Product and Services
Table 92. Sunway Biotech Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Sunway Biotech Recent Developments/Updates
Table 94. Sunway Biotech Competitive Strengths & Weaknesses
Table 95. SIBIONO Basic Information, Area Served and Competitors
Table 96. SIBIONO Major Business
Table 97. SIBIONO Gene Delivery System Product and Services
Table 98. SIBIONO Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. SIBIONO Recent Developments/Updates
Table 100. SIBIONO Competitive Strengths & Weaknesses
Table 101. AnGes Basic Information, Area Served and Competitors
Table 102. AnGes Major Business
Table 103. AnGes Gene Delivery System Product and Services
Table 104. AnGes Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. AnGes Recent Developments/Updates
Table 106. AnGes Competitive Strengths & Weaknesses
Table 107. Orchard Therapeutics Basic Information, Area Served and Competitors
Table 108. Orchard Therapeutics Major Business
Table 109. Orchard Therapeutics Gene Delivery System Product and Services
Table 110. Orchard Therapeutics Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Orchard Therapeutics Recent Developments/Updates
Table 112. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 113. Human Stem Cells Institute Major Business
Table 114. Human Stem Cells Institute Gene Delivery System Product and Services
Table 115. Human Stem Cells Institute Gene Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of Gene Delivery System Upstream (Raw Materials)
Table 117. Gene Delivery System Typical Customers
List of Figure
Figure 1. Gene Delivery System Picture
Figure 2. World Gene Delivery System Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Gene Delivery System Total Market Size (2019-2030) & (USD Million)
Figure 4. World Gene Delivery System Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Delivery System Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Gene Delivery System Revenue (2019-2030) & (USD Million)
Figure 13. Gene Delivery System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 16. World Gene Delivery System Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 18. China Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 23. India Gene Delivery System Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Gene Delivery System by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Delivery System Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Delivery System Markets in 2023
Figure 27. United States VS China: Gene Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Gene Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Gene Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Gene Delivery System Market Size Market Share by Type in 2023
Figure 31. Viral Gene Delivery System
Figure 32. Non-viral Gene Delivery System
Figure 33. World Gene Delivery System Market Size Market Share by Type (2019-2030)
Figure 34. World Gene Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Gene Delivery System Market Size Market Share by Application in 2023
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Others
Figure 39. Gene Delivery System Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
jiaGou

Add To Cart

gouMai

Buy Now